CORE LABORATORIES INC (CLB) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CLB - US21867A1051 - Common Stock
16.55 USD
+0.07 (+0.42%)
16.55 USD
0 (0%)
Taking everything into account, CLB scores 5 out of 10 in our fundamental rating. CLB was compared to 60 industry peers in the Energy Equipment & Services industry. CLB is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CLB does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
CLB had positive earnings in the past year.
In the past year CLB had a positive cash flow from operations.
CLB had positive earnings in 4 of the past 5 years.
CLB had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.43%, CLB is in the better half of the industry, outperforming 68.33% of the companies in the same industry.
CLB's Return On Equity of 11.84% is fine compared to the rest of the industry. CLB outperforms 70.00% of its industry peers.
CLB has a better Return On Invested Capital (9.29%) than 71.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLB is in line with the industry average of 7.49%.
The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROIC | 9.29% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
1.3 Margins
CLB has a Profit Margin (6.21%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CLB has declined.
CLB has a Operating Margin of 11.16%. This is comparable to the rest of the industry: CLB outperforms 60.00% of its industry peers.
CLB's Operating Margin has declined in the last couple of years.
CLB's Gross Margin of 19.95% is on the low side compared to the rest of the industry. CLB is outperformed by 70.00% of its industry peers.
In the last couple of years the Gross Margin of CLB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% |
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLB is creating some value.
Compared to 1 year ago, CLB has about the same amount of shares outstanding.
Compared to 5 years ago, CLB has more shares outstanding
CLB has a better debt/assets ratio than last year.
2.2 Solvency
CLB has an Altman-Z score of 3.31. This indicates that CLB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CLB (3.31) is better than 81.67% of its industry peers.
The Debt to FCF ratio of CLB is 3.32, which is a good value as it means it would take CLB, 3.32 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CLB (3.32) is better than 65.00% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that CLB is not too dependend on debt financing.
CLB has a Debt to Equity ratio of 0.42. This is comparable to the rest of the industry: CLB outperforms 51.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 3.31 |
ROIC/WACC1.07
WACC8.67%
2.3 Liquidity
CLB has a Current Ratio of 2.37. This indicates that CLB is financially healthy and has no problem in meeting its short term obligations.
CLB's Current ratio of 2.37 is fine compared to the rest of the industry. CLB outperforms 68.33% of its industry peers.
CLB has a Quick Ratio of 1.76. This is a normal value and indicates that CLB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CLB (1.76) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 |
3. Growth
3.1 Past
CLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.41%.
CLB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.14% yearly.
CLB shows a decrease in Revenue. In the last year, the revenue decreased by -1.02%.
Measured over the past years, CLB shows a decrease in Revenue. The Revenue has been decreasing by -4.75% on average per year.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
3.2 Future
CLB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.78% yearly.
CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.47% yearly.
EPS Next Y-15.64%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue Next Year-1.9%
Revenue Next 2Y1.16%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
CLB is valuated rather expensively with a Price/Earnings ratio of 21.49.
Compared to the rest of the industry, the Price/Earnings ratio of CLB indicates a somewhat cheap valuation: CLB is cheaper than 61.67% of the companies listed in the same industry.
CLB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.55, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.85 indicates a rather expensive valuation of CLB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLB is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, CLB is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.49 | ||
| Fwd PE | 19.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLB is valued expensively inside the industry as 85.00% of the companies are valued cheaper.
CLB's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.41 | ||
| EV/EBITDA | 11.82 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
5. Dividend
5.1 Amount
With a yearly dividend of 0.24%, CLB is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.28, CLB has a dividend in line with its industry peers.
With a Dividend Yield of 0.24, CLB pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
5.2 History
The dividend of CLB decreases each year by -55.13%.
CLB has paid a dividend for at least 10 years, which is a reliable track record.
CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
CLB pays out 5.83% of its income as dividend. This is a sustainable payout ratio.
DP5.83%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
16.55
+0.07 (+0.42%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)
Earnings (Next)
Inst Owners113.36%
Inst Owner Change-3.6%
Ins Owners1.02%
Ins Owner Change0.11%
Market Cap770.57M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts48
Price Target15.64 (-5.5%)
Short Float %10.3%
Short Ratio8.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.24% |
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)11.51%
EPS NQ rev (1m)1.8%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)2.08%
EPS NY rev (3m)-1.56%
Revenue NQ rev (1m)1.96%
Revenue NQ rev (3m)1.98%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)1.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.49 | ||
| Fwd PE | 19.85 | ||
| P/S | 1.49 | ||
| P/FCF | 22.41 | ||
| P/OCF | 15.5 | ||
| P/B | 2.84 | ||
| P/tB | 4.66 | ||
| EV/EBITDA | 11.82 |
EPS(TTM)0.77
EY4.65%
EPS(NY)0.83
Fwd EY5.04%
FCF(TTM)0.74
FCFY4.46%
OCF(TTM)1.07
OCFY6.45%
SpS11.11
BVpS5.83
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.43% | ||
| ROE | 11.84% | ||
| ROCE | 11.66% | ||
| ROIC | 9.29% | ||
| ROICexc | 9.8% | ||
| ROICexgc | 12.66% | ||
| OM | 11.16% | ||
| PM (TTM) | 6.21% | ||
| GM | 19.95% | ||
| FCFM | 6.64% |
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | 1.58 | ||
| Cap/Depr | 104.6% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 6.66 | ||
| Cash Conversion | 68.62% | ||
| Profit Quality | 107.03% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 1.76 | ||
| Altman-Z | 3.31 |
F-Score7
WACC8.67%
ROIC/WACC1.07
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-15.64%
EPS Next 2Y-2.65%
EPS Next 3Y-0.94%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-1.9%
Revenue Next 2Y1.16%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year10.41%
EBIT Next 3Y4.07%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%
CORE LABORATORIES INC / CLB FAQ
Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?
ChartMill assigns a fundamental rating of 5 / 10 to CLB.
What is the valuation status for CLB stock?
ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.
Can you provide the profitability details for CORE LABORATORIES INC?
CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CLB stock?
The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 21.49 and the Price/Book (PB) ratio is 2.84.
Can you provide the financial health for CLB stock?
The financial health rating of CORE LABORATORIES INC (CLB) is 7 / 10.